Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 1478

1.

Supplementation with oral vitamin D3 and calcium during winter prevents seasonal bone loss: a randomized controlled open-label prospective trial.

Meier C, Woitge HW, Witte K, Lemmer B, Seibel MJ.

J Bone Miner Res. 2004 Aug;19(8):1221-30. Epub 2004 May 24.

PMID:
15231008
[PubMed - indexed for MEDLINE]
2.

Calcium- and vitamin D3-fortified milk reduces bone loss at clinically relevant skeletal sites in older men: a 2-year randomized controlled trial.

Daly RM, Brown M, Bass S, Kukuljan S, Nowson C.

J Bone Miner Res. 2006 Mar;21(3):397-405. Epub 2005 Dec 19.

PMID:
16491287
[PubMed - indexed for MEDLINE]
3.

Elderly women in northern New England exhibit seasonal changes in bone mineral density and calciotropic hormones.

Rosen CJ, Morrison A, Zhou H, Storm D, Hunter SJ, Musgrave K, Chen T, Wei W, Holick MF.

Bone Miner. 1994 May;25(2):83-92.

PMID:
8086854
[PubMed - indexed for MEDLINE]
4.

Circaannual rhythms and interactions of vitamin D metabolites, parathyroid hormone, and biochemical markers of skeletal homeostasis: a prospective study.

Woitge HW, Knothe A, Witte K, Schmidt-Gayk H, Ziegler R, Lemmer B, Seibel MJ.

J Bone Miner Res. 2000 Dec;15(12):2443-50.

PMID:
11127208
[PubMed - indexed for MEDLINE]
5.

The effect of low-dose cholecalciferol and calcium treatment on posttransplant bone loss in renal transplant patients: a prospective study.

Sahin G, Yasar NS, Sirmagul B, Bal C, Yalcin AU.

Ren Fail. 2008;30(10):992-9. doi: 10.1080/08860220802406369.

PMID:
19016151
[PubMed - indexed for MEDLINE]
6.

The treatment of osteoporosis in patients with rheumatoid arthritis receiving glucocorticoids: a comparison of alendronate and intranasal salmon calcitonin.

Tascioglu F, Colak O, Armagan O, Alatas O, Oner C.

Rheumatol Int. 2005 Nov;26(1):21-9. Epub 2005 Feb 2.

PMID:
15688191
[PubMed - indexed for MEDLINE]
7.

Effects of oral alendronate in elderly patients with osteoporosis and mild primary hyperparathyroidism.

Rossini M, Gatti D, Isaia G, Sartori L, Braga V, Adami S.

J Bone Miner Res. 2001 Jan;16(1):113-9.

PMID:
11149474
[PubMed - indexed for MEDLINE]
8.

Prevention of bone loss after heart transplantation with antiresorptive therapy: a pilot study.

Shane E, Rodino MA, McMahon DJ, Addesso V, Staron RB, Seibel MJ, Mancini D, Michler RE, Lo SH.

J Heart Lung Transplant. 1998 Nov;17(11):1089-96.

PMID:
9855448
[PubMed - indexed for MEDLINE]
9.

Oral daily ibandronate prevents bone loss in early postmenopausal women without osteoporosis.

McClung MR, Wasnich RD, Recker R, Cauley JA, Chesnut CH 3rd, Ensrud KE, Burdeska A, Mills T; Oral Ibandronate Study Group.

J Bone Miner Res. 2004 Jan;19(1):11-8.

PMID:
14753731
[PubMed - indexed for MEDLINE]
10.

Early changes in biochemical markers of bone turnover predict the long-term response to alendronate therapy in representative elderly women: a randomized clinical trial.

Greenspan SL, Parker RA, Ferguson L, Rosen HN, Maitland-Ramsey L, Karpf DB.

J Bone Miner Res. 1998 Sep;13(9):1431-8.

PMID:
9738515
[PubMed - indexed for MEDLINE]
11.
12.

Effect of intermittent administration of 200 IU intranasal salmon calcitonin and low doses of 1alpha(OH) vitamin D3 on bone mineral density of the lumbar spine and hip region and biochemical bone markers in women with postmenopausal osteoporosis: a pilot study.

Kaskani E, Lyritis GP, Kosmidis C, Galanos A, Andypas G, Chorianopoulos K, Giagiosis A, Iliadou K, Karagianis A, Katsimichas K, Koskinas A, Matsouka K.

Clin Rheumatol. 2005 Jun;24(3):232-8. Epub 2005 Jan 13.

PMID:
15647969
[PubMed - indexed for MEDLINE]
13.

Bone mass and markers of bone and calcium metabolism in postmenopausal women treated with 1,25-dihydroxyvitamin D (Calcitriol) for four years.

Sairanen S, Kärkkäinen M, Tähtelä R, Laitinen K, Mäkelä P, Lamberg-Allardt C, Välimäki MJ.

Calcif Tissue Int. 2000 Aug;67(2):122-7.

PMID:
10920216
[PubMed - indexed for MEDLINE]
14.
15.

Changes in bone turnover markers after calcium-enriched milk supplementation in healthy postmenopausal women: a randomized, double-blind, prospective clinical trial.

Palacios S, Castelo-Branco C, Cifuentes I, von Helde S, Baró L, Tapia-Ruano C, Menéndez C, Rueda C.

Menopause. 2005 Jan-Feb;12(1):63-8.

PMID:
15668602
[PubMed - indexed for MEDLINE]
16.

Cyclical etidronate reverses bone loss of the spine and proximal femur in patients with established corticosteroid-induced osteoporosis.

Struys A, Snelder AA, Mulder H.

Am J Med. 1995 Sep;99(3):235-42.

PMID:
7653482
[PubMed - indexed for MEDLINE]
17.

Effectiveness and safety of vitamin D in relation to bone health.

Cranney A, Horsley T, O'Donnell S, Weiler H, Puil L, Ooi D, Atkinson S, Ward L, Moher D, Hanley D, Fang M, Yazdi F, Garritty C, Sampson M, Barrowman N, Tsertsvadze A, Mamaladze V.

Evid Rep Technol Assess (Full Rep). 2007 Aug;(158):1-235. Review.

PMID:
18088161
[PubMed - indexed for MEDLINE]
Free Article
18.

Growth hormone favorably affects bone turnover and bone mineral density in patients with short bowel syndrome undergoing intestinal rehabilitation.

Tangpricha V, Luo M, Fernández-Estívariz C, Gu LH, Bazargan N, Klapproth JM, Sitaraman SV, Galloway JR, Leader LM, Ziegler TR.

JPEN J Parenter Enteral Nutr. 2006 Nov-Dec;30(6):480-6.

PMID:
17047171
[PubMed - indexed for MEDLINE]
19.

Positive effect of alendronate on bone mineral density and markers of bone turnover in patients with rheumatoid arthritis on chronic treatment with low-dose prednisone: a randomized, double-blind, placebo-controlled trial.

Lems WF, Lodder MC, Lips P, Bijlsma JW, Geusens P, Schrameijer N, van de Ven CM, Dijkmans BA.

Osteoporos Int. 2006;17(5):716-23. Epub 2006 Feb 3.

PMID:
16463007
[PubMed - indexed for MEDLINE]
20.

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk